ID   WA25
AC   CVCL_E080
SY   WA-25; WAe025-A
DR   hPSCreg; WAe025-A
DR   ISCR; 2001
DR   NIHhESC; NIHhESC-12-0196
DR   WiCell; wa25
DR   Wikidata; Q54993532
RX   PubMed=28445466;
WW   https://www.wicell.org/media/Ads/2013.ISSCR.DerivationFinal.pdf
CC   Group: Clinical grade hESC cell line.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0196.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 8,14
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
RX   PubMed=28445466; DOI=10.1038/nature22312;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative P53 mutations.";
RL   Nature 545:229-233(2017).
//